Skip to main content
. Author manuscript; available in PMC: 2019 Oct 15.
Published in final edited form as: Clin Cancer Res. 2019 Jan 16;25(8):2471–2482. doi: 10.1158/1078-0432.CCR-18-3423

Fig. 2. [18F]FSPG uptake is decreased in drug-resistant cells.

Fig. 2

(A) Molecular structure of [18F]FSPG. (B and C) [18F]FSPG cell uptake and accumulation following 60 min incubation in A2780 cell lines (B) and PEO cell lines (C). Scatter plots represent biological repeats performed in triplicate. *, P < 0.05; **, P < 0.01; ***, P < 0.001, ****, P < 0.0001.